Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...
Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how ...
The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
but the impact of poor valve performance is magnified in patients with a small aortic annulus, who are at risk of receiving a valve that is not adequate for their cardiac requirements," said Howard C.